Join to View Full Profile
1500 Duarte RdDuarte, CA 91010
Phone+1 626-359-8111
Fax+1 626-218-5310
Dr. Cristea is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Florida College of Medicine JacksonvilleFellowship, Hematology and Medical Oncology, 1998 - 2000
Rutgers Health/Monmouth Medical CenterResidency, Internal Medicine, 1995 - 1998
University of Medicine and Pharmacy ‘Gr T Popa” Iasi Class of 1992
Certifications & Licensure
NC State Medical License 2000 - Present
CA State Medical License 2004 - 2026
FL State Medical License 1999 - 2006
MI State Medical License 1997 - 1998
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Clinical Trials
- Intraperitoneal Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Cancer of the Peritoneal Cavity Start of enrollment: 2009 Jan 01
- Ipilimumab in Treating Patients With Metastatic or Recurrent Human Papilloma Virus-Related Cervical Cancer Start of enrollment: 2012 Dec 03
- Cabozantinib S-Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer Start of enrollment: 2013 May 08
- Join now to see all
Publications & Presentations
PubMed
- 2 citationsA phase 2 trial exploring the significance of homologous recombination status in patients with platinum sensitive or platinum resistant relapsed ovarian cancer receivi...Joyce F Liu, Niya Xiong, Robert M Wenham, Andrea Wahner-Hendrickson, Deborah K Armstrong
Gynecologic Oncology. 2024-08-01 - 6 citationsTargeting PARG induces tumor cell growth inhibition and antitumor immune response by reducing phosphorylated STAT3 in ovarian cancer.Antons Martincuks, Chunyan Zhang, Theresa Austria, Yi-Jia Li, Rui Huang
Journal for Immunotherapy of Cancer. 2024-04-05 - 5 citationsA phase I study of Mirvetuximab Soravtansine and gemcitabine in patients with FRα-positive recurrent ovarian, primary peritoneal, fallopian tube, or endometrial cancer...Mihaela C Cristea, Daphne Stewart, Timothy Synold, Nora Ruel, Joanne Mortimer
Gynecologic Oncology. 2024-03-01
Press Mentions
City of Hope Presents New Cancer Research at American Society of Clinical Oncology MeetingMay 31st, 2016
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
